These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17766999)

  • 1. Comment on: a case of Raynaud's phenomenon in mixed connective tissue disease responding to Rituximab therapy response.
    Dunkley L; Green M; Gough A
    Rheumatology (Oxford); 2007 Oct; 46(10):1628-9. PubMed ID: 17766999
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of Raynaud's phenomenon in mixed connective tissue disease responding to rituximab therapy.
    Haroon M; O'Gradaigh D; Foley-Nolan D
    Rheumatology (Oxford); 2007 Apr; 46(4):718-9. PubMed ID: 17289791
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thermographic assessment of Raynaud's phenomenon in childhood mixed connective tissue disease].
    Yokota S; Kuriyama T; Takahashi Y; Mori M; Shike H; Ibe M; Mitsuda T; Aihara Y
    Ryumachi; 1994 Dec; 34(6):955-60. PubMed ID: 7863385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of undifferentiated connective tissue disease: is it a distinct clinical entity?
    Mosca M; Tani C; Bombardieri S
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):328-32. PubMed ID: 18414458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raynaud's phenomenon and initially seronegative mixed connective tissue disease.
    Ellman MH; Pachman L; Medof ME
    J Rheumatol; 1981; 8(4):632-4. PubMed ID: 6975377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of longterm nifedipine in a patient with Raynaud's syndrome secondary to mixed connective tissue disease.
    Sarkozi J; McCarthy DD; Lee P
    J Rheumatol; 1984 Jun; 11(3):408-10. PubMed ID: 6737386
    [No Abstract]   [Full Text] [Related]  

  • 7. Raynaud's phenomenon in mixed connective tissue disease.
    Grader-Beck T; Wigley FM
    Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe corticoid-refractory autoimmune thrombocytopenia associated with mixed connective tissue disease (Sharp's syndrome). Treatment with rituximab].
    Rudolph SE; Kouba M; Hrdlicka P
    Dtsch Med Wochenschr; 2009 Sep; 134(36):1734-8. PubMed ID: 19718594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual cause of abdominal fullness in a patient with Raynaud's phenomenon. Mixed connective tissue disease.
    Hokama A; Kishimoto K; Nakamoto M; Kinjo N; Kinjo F; Fujita J
    Gut; 2008 Jun; 57(6):733, 820. PubMed ID: 18477675
    [No Abstract]   [Full Text] [Related]  

  • 10. [Raynaud's syndrome: diagnosis and therapy].
    Mahler F
    Ther Umsch; 1985 Oct; 42(10):671-7. PubMed ID: 3909486
    [No Abstract]   [Full Text] [Related]  

  • 11. [Whole-blood and plasma viscosity in two cases of mixed connective tissue disease with Raynaud's phenomenon and cold agglutinemia].
    Nakazato K; Sakurai T; Kubota K; Kurabayashi H; Tamura J; Shirakura T
    Rinsho Byori; 1988 Oct; 36(10):1201-4. PubMed ID: 3246733
    [No Abstract]   [Full Text] [Related]  

  • 12. Refractory severe connective tissue disease thrombocytopenia: is rituximab treatment effective and safe?
    Zheng WJ; Zhang X; Wang Q; Xu D; Zeng XF; Zhang FC
    Ann Rheum Dis; 2009 Jun; 68(6):1077-8. PubMed ID: 19435726
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed connective tissue disease.
    Christopher-Stine L; Wigley F
    J Rheumatol; 2003 Dec; 30(12):2725-7. PubMed ID: 14719225
    [No Abstract]   [Full Text] [Related]  

  • 14. [Differential diagnostic considerations in Raynaud's phenomenon].
    Wollersheim H; Thien T
    Ned Tijdschr Geneeskd; 1986 Mar; 130(9):385-8. PubMed ID: 3960184
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mixed connective tissue disease].
    Prøven A
    Tidsskr Nor Laegeforen; 1992 Feb; 112(4):479-82. PubMed ID: 1553696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulse cyclophosphamide decreases sympathetic postganglionic activity, controls alveolitis, and normalizes vascular tone dysfunction (Raynaud's phenomenon) in a case of early systemic sclerosis.
    Casale R; Generini S; Luppi F; Pignone A; Matucci-Cerinic M
    Arthritis Rheum; 2004 Aug; 51(4):665-9. PubMed ID: 15334442
    [No Abstract]   [Full Text] [Related]  

  • 17. Trigeminal neuralgia as the first manifestation of mixed connective tissue disorder.
    Hojaili B; Barland P
    J Clin Rheumatol; 2006 Jun; 12(3):145-7. PubMed ID: 16755246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe ischemia following treatment with rituximab in a patient with mixed connective tissue disease: an unusual complication.
    Vela P; Sivera F; Batlle-Gualda E; Mayor M; García-Manzanares A; Pascual E
    Lupus; 2010 Jul; 19(8):1005-6. PubMed ID: 20581023
    [No Abstract]   [Full Text] [Related]  

  • 19. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
    Curr Opin Rheumatol; 1994 Nov; 6(6):B145-50. PubMed ID: 7865371
    [No Abstract]   [Full Text] [Related]  

  • 20. Mixed connective tissue disease with protein-losing enteropathy: discussion of the treatment strategy.
    Chao CT; Lai CY; Chang PL; Wu HS; Wu VC; Wang WJ
    J Clin Rheumatol; 2011 Aug; 17(5):286-7. PubMed ID: 21778905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.